A detailed history of Delta Investment Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Delta Investment Management, LLC holds 1,734 shares of LLY stock, worth $1.33 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
1,734
Previous 1,375 26.11%
Holding current value
$1.33 Million
Previous $1.24 Million 23.47%
% of portfolio
0.36%
Previous 0.31%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $277,198 - $344,647
359 Added 26.11%
1,734 $1.54 Million
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $40,592 - $50,906
56 Added 4.25%
1,375 $1.24 Million
Q1 2024

May 08, 2024

SELL
$592.2 - $792.28 $9,475 - $12,676
-16 Reduced 1.2%
1,319 $1.03 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $66,074 - $91,093
152 Added 12.85%
1,335 $717,000
Q2 2023

Aug 03, 2023

SELL
$350.74 - $468.98 $1,052 - $1,406
-3 Reduced 0.25%
1,183 $554,000
Q1 2023

May 05, 2023

SELL
$310.63 - $364.82 $27,956 - $32,833
-90 Reduced 7.05%
1,186 $407,000
Q4 2022

Jan 19, 2023

BUY
$321.55 - $374.67 $11,254 - $13,113
35 Added 2.82%
1,276 $0
Q3 2022

Oct 21, 2022

BUY
$296.48 - $337.87 $367,931 - $419,296
1,241 New
1,241 $401,000
Q4 2021

Feb 07, 2022

SELL
$224.85 - $279.04 $2.24 Million - $2.78 Million
-9,961 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$221.6 - $272.71 $2.21 Million - $2.72 Million
9,961 New
9,961 $2.3 Million
Q3 2020

Nov 12, 2020

SELL
$146.22 - $169.13 $2.35 Million - $2.72 Million
-16,078 Closed
0 $0
Q2 2020

Aug 05, 2020

BUY
$136.42 - $164.18 $2.19 Million - $2.64 Million
16,078 New
16,078 $2.64 Million
Q2 2019

Aug 08, 2019

SELL
$110.79 - $129.32 $2.01 Million - $2.34 Million
-18,110 Closed
0 $0
Q1 2019

May 07, 2019

BUY
$111.31 - $131.02 $2.02 Million - $2.37 Million
18,110 New
18,110 $2.35 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Delta Investment Management, LLC Portfolio

Follow Delta Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Delta Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Delta Investment Management, LLC with notifications on news.